Perspective Therapeutic Area: Rett Syndrome
According to NORD, There are more than 7,000 known rare diseases, and the number of Americans living with a rare disease is estimated at 25-30 million.
At Acadia, innovation means striving to bring potential new treatment options to patients living with diseases that can take so much away. Our recently announced collaboration with Stoke Therapeutics will enable that and more.
In a recent conversation with the Child Neurology Foundation, Kathie Bishop, Acadia’s Chief Scientific Officer and Head of Rare Disease, shared her perspective on the latest innovations in treating childhood rare diseases, such as Rett syndrome.